MedPath

A randomised, comparative study of vonoprazan and esomeprazole 20mg in the treatment of gastric ulcers due to endoscopic submucosal dissection (ESD) for gastric mucosal cancer.

Not Applicable
Conditions
mucosal cancer of the stomach
Registration Number
JPRN-UMIN000017077
Lead Sponsor
Machida municipal hospital
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete: follow-up complete
Sex
All
Target Recruitment
80
Inclusion Criteria

Not provided

Exclusion Criteria

1.Hypersensitivity of esomeprazole and vonoprzan. 2.Taking medicine which are possible to interact with vonoprazan or esomeprazole. 3.under pregnancy or breast-feeding. 4.Impossibility of oral intake. 5.Past history of resection of upper GI tract.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
A period to cure post ESD ulcer of the stomach.
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath